Catheter-related vancomycin-resistant Enterococcus faecium bacteremia:: Clinical and molecular epidemiology

被引:13
作者
Raad, II
Hanna, HA
Boktour, M
Jabbour, N
Hachem, RY
Darouiche, RO
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Baylor Coll Med, Ctr Prosthesis Infect, Houston, TX 77030 USA
关键词
D O I
10.1086/502598
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To study the clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium organisms causing catheter-related bacteremia in patients with cancer. DESIGN: Retrospective case-control study. SETTING: University of Texas M. D. Anderson Cancer Center, a tertiary-care hospital in Houston, Texas. PATIENTS: Case-patients were patients with cancer who had catheter-related vancomycin-resistant E. faecium bacteremia and control-patients were patients with cancer and vancomycin-resistant E. faecium gastrointestinal colonization without infection. RESULTS: Ten case-patients with catheter-related vancomycin-resistant E. faecium bacteremia were compared with 30 control-patients with gastrointestinal colonization by vancomycin-resistant E. faecium. Patients with catheter-related vancomycin-resistant E. faecium bacteremia were more likely to have required mechanical ventilation (P < .01), received total parenteral nutrition (P < .01), and had polyurethane catheters (P < .01) inserted in the femoral vein (P = .01). With the use of pulsed-field gel electrophoresis, 4 of the 10 catheter-related vancomycin-resistant E. faecium bacteremia isolates were genetically indistinguishable, whereas only 2 of the 30 control vancomycin-resistant E. faecium isolates displayed this same DNA pattern (P= .03). CONCLUSION: This study suggests that catheter-related vancomycin-resistant E. faecium bacteremia occurs more frequently in patients who receive total parenteral nutrition, mechanical ventilation, and femoral catheters.
引用
收藏
页码:658 / 661
页数:4
相关论文
共 18 条
[1]   Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia [J].
Beezhold, DW ;
Slaughter, S ;
Hayden, MK ;
Matushek, M ;
Nathan, C ;
Trenholme, GM ;
Weinstein, RA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :704-706
[2]   Preventing central venous catheter-related infection in a surgical intensive-care unit [J].
Bijma, R ;
Girbes, AR ;
Kleijer, DJ ;
Zwaveling, JH .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (09) :618-620
[3]   Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci [J].
Bonten, MJM ;
Hayden, MK ;
Nathan, C ;
vanVoorhis, J ;
Matushek, M ;
Slaughter, S ;
Rice, T ;
Weinstein, RA .
LANCET, 1996, 348 (9042) :1615-1619
[4]   Antimicrobial resistance in intensive care units [J].
Fridkin, SK ;
Gaynes, RP .
CLINICS IN CHEST MEDICINE, 1999, 20 (02) :303-+
[5]   Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center [J].
Hanna, H ;
Umphrey, J ;
Tarrand, J ;
Mendoza, M ;
Raad, I .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (04) :217-219
[6]   THE EFFECT OF CATHETER TYPE AND SITE ON INFECTION-RATES IN TOTAL PARENTERAL-NUTRITION PATIENTS [J].
KEMP, L ;
BURGE, J ;
CHOBAN, P ;
HARDEN, J ;
MIRTALLO, J ;
FLANCBAUM, L .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1994, 18 (01) :71-74
[7]  
Leach TS, 2000, CLIN INFECT DIS, V31, P224
[8]  
Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
[9]   Complications of femoral and subclavian venous catheterization in critically ill patients - A randomized controlled trial [J].
Merrer, J ;
De Jonghe, B ;
Golliot, F ;
Lefrant, JY ;
Raffy, B ;
Barre, E ;
Rigaud, JP ;
Casciani, D ;
Misset, B ;
Bosquet, C ;
Outin, H ;
Brun-Buisson, C ;
Nitenberg, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06) :700-707
[10]   The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium [J].
Moellering, RC ;
Linden, PK ;
Reinhardt, J ;
Blumberg, EA ;
Bompart, F ;
Talbot, GH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) :251-261